Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...
Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...
The Healthy on MSN4d
Nearly 7,000 Bottles of a Heart and Diabetes Medication Recalled in At Least One StateAround 20 million Americans reportedly trust this medication—here are the recall details, and the unusual error that caused it.
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
For further earnings highlights, click. Granules, which holds a 30% share of the global paracetamol market, supplies the drug as an active pharmaceutical ingredient (API) and as a finished dosage ...
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...
Hyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of Riaz Ahmed ...
Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI ...
Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback